Peptides for Joint & Connective Tissue Research BPC-157 · TB-500 · GHK-Cu · KPV · Repair Pathway Research · ≥99% HPLC · Janoshik COA
Joint and connective tissue repair peptide research targets multiple pathways: NOS/VEGFR2/EGF signaling (BPC-157), actin-sequestering anti-inflammatory (TB-500), ECM and collagen remodeling (GHK-Cu), MC1R anti-inflammatory (KPV), and EPOR pathway (ARA-290). QSC stocks all joint and connective tissue research peptides at ≥99% HPLC with Janoshik COA.
Joint and connective tissue research peptides include BPC-157 (NOS/VEGFR2/EGF, tendon research), TB-500 (Thymosin Beta-4, systemic anti-inflammatory), GHK-Cu (ECM/collagen remodeling), KPV (MC1R pathway), and ARA-290 (EPOR signaling). QSC stocks all at ≥99% HPLC with Janoshik COA. Research use only.
Is BPC-157 studied for tendon and ligament repair?
Yes — BPC-157 (Body Protection Compound 157) is one of the most extensively studied peptides for tendon, ligament, and connective tissue research. Its mechanism involves NOS pathway activation, VEGFR2 upregulation (angiogenesis), and EGF receptor signaling. Published research includes tendon healing models, GI repair, and neuroprotection studies. QSC stocks BPC-157 at ≥99% HPLC with Janoshik COA. Research use only.
What is the BPC-157 + TB-500 research combination?
BPC-157 and TB-500 (Thymosin Beta-4) are frequently combined in repair research protocols due to their complementary mechanisms — BPC-157 provides localized NOS/VEGF/EGF signaling for structural repair while TB-500 provides systemic anti-inflammatory and stem cell homing effects. QSC can supply both compounds. Research use only.
Research Use Only: All QSC products sold strictly for in vitro laboratory research. Not for human or veterinary use. Information on this page is educational only and does not constitute medical advice.
